King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Antonello Podda
Dr. Antonello Podda is a Consultant Paediatric Haematologist/Oncologist specialising in paediatric solid tumours, Langerhans cell histiocytosis, and rare paediatric malignancies — an internationally trained paediatric oncologist in Riyadh, Saudi Arabia bringing 20+ years of clinical and academic experience to international families. He previously held senior academic and clinical appointments at a leading US comprehensive cancer centre and children's hospital before joining the tertiary oncology programme in Riyadh.
- Consultant Paediatric Oncologist with 20+ years of clinical experience in solid tumours
- Former senior faculty at a leading US academic cancer centre and children's hospital
- Published researcher on paediatric adrenal tumour immunotherapy disparities
- Author on Langerhans cell histiocytosis, CD30 tumours, orbital medulloepithelioma, and paediatric angiosarcoma HIPEC
- Collaborator on Saudi paediatric palliative care research
Qualifications & Credentials
Medical Degrees
- MD — Doctor of Medicine
- Paediatric Residency
Fellowships & Special Training
- Fellowship in Paediatric Haematology/Oncology
- Subspecialty Training in Paediatric Solid Tumours
- Advanced Clinical Training in Rare Paediatric Malignancies
Certifications & Accreditations
- Board Certification in Paediatric Haematology/Oncology (international)
- Saudi Commission for Health Specialties (SCFHS) — Registered Consultant
- American Society of Clinical Oncology (ASCO) — Member
Areas of Expertise
Major Conditions Treated
- Paediatric Neuroblastoma
- Rhabdomyosarcoma
- Paediatric Adrenal Tumours
- Langerhans Cell Histiocytosis (LCH)
- Wilms Tumour
- Paediatric Angiosarcoma
- Orbital Medulloepithelioma
- CD30+ Lymphoproliferative Disorders
- Paediatric Germ Cell Tumours
- Paediatric Soft Tissue Sarcomas
Sub-specialties
- Paediatric Solid Tumours: Risk-adapted chemotherapy, immunotherapy, and multidisciplinary management for paediatric neuroblastoma, rhabdomyosarcoma, and adrenal tumours — a leading paediatric solid tumour specialist in Riyadh for international families.
- Langerhans Cell Histiocytosis & Rare Disorders: Comprehensive management of LCH and rare paediatric histiocytic disorders drawing on international experience.
- Advanced Paediatric Surgical Oncology Coordination: Co-management with surgical oncology teams for paediatric angiosarcoma HIPEC and complex solid tumour resections.
Advanced Procedures & Treatments
- Risk-Adapted Chemotherapy Protocols
- Paediatric Immunotherapy (Including Adrenal Tumours)
- LCH-Directed Therapy (Vinblastine, BRAF Inhibitors)
- Targeted Therapy for Paediatric Sarcomas
- Multidisciplinary Tumour Board Management
- Coordination with Paediatric HIPEC Teams
- Paediatric Palliative & Supportive Care
- Long-Term Survivorship Follow-Up
Professional Experience
Current Affiliation
- Consultant, Paediatric Haematology/Oncology (Solid Tumours) — King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia (Present)
Past Affiliations
- Faculty & Consultant — University of Miami Sylvester Comprehensive Cancer Center, USA (Past)
- Consultant Paediatric Haematology/Oncology — Holtz Children's Hospital, Miami, USA (Past)
Academic & Research Roles
- Former academic appointment — University of Miami Miller School of Medicine
- Contributing author — peer-reviewed paediatric oncology journals
- Participant — KFSHRC Paediatric Multidisciplinary Tumour Board
Key Achievements
- 20+ years of international paediatric oncology clinical experience
- Published lead or co-author on paediatric adrenal tumour immunotherapy disparities
- Contributor to research on paediatric angiosarcoma HIPEC, CD30+ lymphoproliferative disorders, and orbital medulloepithelioma
- Co-author on Saudi paediatric palliative care research
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Clinical Oncology (ASCO)
- American Society of Paediatric Hematology/Oncology (ASPHO)
- International Society of Paediatric Oncology (SIOP)
Research & Publications
Published Papers (Selected)
- Podda A, et al. Disparities in Immunotherapy for Paediatric Adrenal Tumours. Pediatric Blood & Cancer. 2020.
- Podda A, et al. Paediatric Angiosarcoma — HIPEC Experience.
- Podda A, et al. Langerhans Cell Histiocytosis — Clinical Series.
- Podda A, et al. CD30+ Lymphoproliferative Disorders in Children.
- Al-Kofide A, Podda A, et al. Paediatric Palliative Care in Oncology — Saudi Experience. 2023. PMC10366288.
Ongoing Research & Clinical Interests
- Paediatric adrenal tumour immunotherapy
- Langerhans cell histiocytosis and rare histiocytic disorders
- Paediatric sarcoma outcomes
- International paediatric oncology disparities
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Paediatric Oncology Consultation | ₹1,000 – ₹2,500 | $12 – $30 |
| Paediatric Chemotherapy (per cycle) | ₹25,000 – ₹1,75,000 | $300 – $2,100 |
| Paediatric Stem Cell Transplant | ₹18,00,000 – ₹35,00,000 | $21,700 – $42,200 |
| Tumour Biopsy & Molecular Profiling | ₹15,000 – ₹75,000 | $180 – $900 |
| Targeted / Immunotherapy (per cycle) | ₹80,000 – ₹3,00,000 | $960 – $3,600 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Antonello Podda use in Paediatric Haematology / Oncology — Solid Tumours treatment?
Dr. Antonello Podda uses advanced paediatric oncology technologies including risk-adapted chemotherapy protocols, paediatric immunotherapy (including for adrenal tumours), LCH-directed therapy with BRAF inhibitors, targeted therapy for paediatric sarcomas, coordination with paediatric HIPEC surgical teams, and multidisciplinary tumour board management. Virtual consultations and remote second opinions are also available to international families through Cancer Rounds.
2. What conditions does Dr. Antonello Podda specialize in treating?
Dr. Antonello Podda specialises in Paediatric Solid Tumour Oncology, treating paediatric neuroblastoma, rhabdomyosarcoma, adrenal tumours, Langerhans cell histiocytosis (LCH), Wilms tumour, paediatric angiosarcoma, orbital medulloepithelioma, CD30+ lymphoproliferative disorders, germ cell tumours, and paediatric soft tissue sarcomas. International families seeking the best paediatric oncologist in India or Saudi Arabia benefit from his dual US–Middle East training.
3. How do I book an appointment with Dr. Antonello Podda?
Appointments with Dr. Antonello Podda can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Antonello Podda?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Antonello Podda, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Antonello Podda offer second opinions for Paediatric Haematology / Oncology — Solid Tumours cases?
Yes. Second opinion consultations for Paediatric Solid Tumour and rare paediatric malignancy cases can be arranged via Cancer Rounds, enabling international families to review complex paediatric oncology cases with Dr. Antonello Podda, who brings extensive US and Middle East clinical experience.
